Kenneth Frazier

Kenneth Carleton Frazier is an American business executive. He is the chairman and CEO of the pharmaceutical company Merck & Co.. After joining Merck & Co. as general counsel, he directed the company's defense against litigation over the anti-inflammatory drug Vioxx. Frazier is the first African American man to lead a major pharmaceutical company. He was elected to the American Philosophical Society in 2018.